| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antigenicity and Immunogenicity of Synthetic Peptides
|
Van Regenmortel, M.H.V.
|
|
2001
|
29 |
3-4 |
p. 209-213
5 p.
|
artikel
|
| 2 |
Chemoselective Ligation and Antigen Vectorization
|
Gras-Masse, Hélène
|
|
2001
|
29 |
3-4 |
p. 183-188
6 p.
|
artikel
|
| 3 |
Circumventing T-cell Tolerance to Tumour Antigens
|
Kessels, H.W.H.G.
|
|
2001
|
29 |
3-4 |
p. 277-283
7 p.
|
artikel
|
| 4 |
Designing Peptide Vaccines for Cellular Cross-Presentation
|
van Endert, Peter M.
|
|
2001
|
29 |
3-4 |
p. 285-288
4 p.
|
artikel
|
| 5 |
Dr Constant (Stan) Huygelen 1929–2001
|
Andre, Francis
|
|
2001
|
29 |
3-4 |
p. 155-
1 p.
|
artikel
|
| 6 |
From Combinatorial Libraries to MHC Ligand Motifs, T-cell Superagonists and Antagonists
|
Jung, Günther
|
|
2001
|
29 |
3-4 |
p. 179-181
3 p.
|
artikel
|
| 7 |
Harry M. Meyer, Jr, M.D. 1928–2001
|
Parkman, Paul D.
|
|
2001
|
29 |
3-4 |
p. 157-158
2 p.
|
artikel
|
| 8 |
Immunological Characterization of Peptide Mimetics of Carbohydrate Antigens in Vaccine Design Strategies
|
Monzavi-Karbassi, Behjatolah
|
|
2001
|
29 |
3-4 |
p. 249-257
9 p.
|
artikel
|
| 9 |
International Symposium on Immunological Applications of Synthetic Peptides
|
|
|
2001
|
29 |
3-4 |
p. 153-
1 p.
|
artikel
|
| 10 |
Long Synthetic Peptides as Biologically Active Proteins: The Example of the Chemokines
|
Thierry, Anne-Christine
|
|
2001
|
29 |
3-4 |
p. 259-263
5 p.
|
artikel
|
| 11 |
Manipulation of Epitope Function by Modification of Peptide Structure: A Minireview
|
Hudecz, Ferenc
|
|
2001
|
29 |
3-4 |
p. 197-207
11 p.
|
artikel
|
| 12 |
Mapping of Natural Anti-Factor VIII Antibodies in Plasma Pools from Healthy Donors: Use of Rationally Designed Synthetic Peptides
|
Di Giambattista, Mario
|
|
2001
|
29 |
3-4 |
p. 229-232
4 p.
|
artikel
|
| 13 |
Peptide Analysis by Rapid, Orthogonal Technologies with High Separation Selectivities and Sensitivities
|
Hearn, Milton T.W.
|
|
2001
|
29 |
3-4 |
p. 159-178
20 p.
|
artikel
|
| 14 |
Peptide-based Synthetic Recombinant Vaccines with Anti-viral Efficacy
|
Arnon, R.
|
|
2001
|
29 |
3-4 |
p. 237-242
6 p.
|
artikel
|
| 15 |
Stability and CTL-activity of P40/ELA Melanoma Vaccine Candidate
|
Beck, A.
|
|
2001
|
29 |
3-4 |
p. 293-298
6 p.
|
artikel
|
| 16 |
Structure-based Design and Evaluation of MHC Class II Binding Peptides
|
de Haan, Ellen C.
|
|
2001
|
29 |
3-4 |
p. 289-292
4 p.
|
artikel
|
| 17 |
Synthetic Peptide-based Vaccine and Diagnostic System for Effective Control of FMD
|
Wang, Chang Yi
|
|
2001
|
29 |
3-4 |
p. 221-228
8 p.
|
artikel
|
| 18 |
Synthetic Peptides as Functional Mimics of a Viral Discontinuous Antigenic Site
|
Villén, Judit
|
|
2001
|
29 |
3-4 |
p. 265-269
5 p.
|
artikel
|
| 19 |
Synthetic Peptide Vaccines: Unexpected Fulfillment of Discarded Hope?
|
Meloen, Rob H.
|
|
2001
|
29 |
3-4 |
p. 233-236
4 p.
|
artikel
|
| 20 |
Tandem Peptide Ligation for Synthetic and Natural Biologicals
|
Tam, J.P.
|
|
2001
|
29 |
3-4 |
p. 189-196
8 p.
|
artikel
|
| 21 |
The Development of a Mimotope-based Synthetic Peptide Vaccine Against Respiratory Syncytial Virus
|
Steward, Michael W.
|
|
2001
|
29 |
3-4 |
p. 215-219
5 p.
|
artikel
|
| 22 |
The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation
|
Sette, A.
|
|
2001
|
29 |
3-4 |
p. 271-276
6 p.
|
artikel
|
| 23 |
Towards Alzheimer's β-Amyloid Vaccination
|
Frenkel, Dan
|
|
2001
|
29 |
3-4 |
p. 243-247
5 p.
|
artikel
|
Tijdschrift beschrijving